4.19
Precigen Inc Aktie (PGEN) Neueste Nachrichten
Precigen (PGEN) Is Up 7.4% After Surging Revenue And Wider 2025 Losses Are Reported – Has The Bull Case Changed? - simplywall.st
Precigen Stock Hits Day Low of $3.94 Amid Price Pressure - Markets Mojo
PGEN Should I Buy - Intellectia AI
Insider Selling: Precigen (NASDAQ:PGEN) Director Sells 4,772,781 Shares of Stock - MarketBeat
PGEN SEC FilingsPrecigen Inc 10-K, 10-Q, 8-K Forms - Stock Titan
PGEN.O Technical Analysis & Stock Price Forecast - Intellectia AI
PGEN PE Ratio & Valuation, Is PGEN Overvalued - Intellectia AI
Precigen, Inc. (NASDAQ:PGEN) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Precigen gains after 2025 results on Papzimeos' outlook - MSN
Precigen, Inc. (NASDAQ:PGEN) Q4 2025 earnings call transcript - MSN
PGEN.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
4,772,781 Precigen (PGEN) shares sold by entities tied to Randal Kirk - Stock Titan
Randal J. Kirk (PGEN) entities sell 4.8M shares, still hold over one-third stake - Stock Titan
Precigen Details Papzimeos Commercial Launch, Hub Growth and J-Code Catalyst at H.C. Wainwright Chat - MarketBeat
Precigen (NASDAQ:PGEN) Stock Price Up 11.2%What's Next? - MarketBeat
These analysts boost their forecasts on Precigen following Q4 results - MSN
Precigen to Participate in a Fireside Chat with H.C. Wainwright on March 31 - StreetInsider
[144] PRECIGEN, INC. SEC Filing - Stock Titan
Precigen (NASDAQ:PGEN) Shares Down 9%Time to Sell? - MarketBeat
HC Wainwright Estimates Precigen's Q1 Earnings (NASDAQ:PGEN) - MarketBeat
Precigen (PGEN) Is Up 11.9% After PAPZIMEOS’ Launch Shifts Focus Toward Commercial Revenue Model - simplywall.st
Precigen, Inc. (PGEN) reports Q4 loss, lags revenue estimates - MSN
Precigen (NASDAQ:PGEN) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Precigen, Inc.FinancialContentStock Market - markets.financialcontent.com
HC Wainwright Has Positive Estimate for Precigen Q3 Earnings - MarketBeat
Discover Precigen And 2 Other Insider-Favored Growth Stocks - Yahoo Finance
Is It Too Late To Consider Precigen (PGEN) After Its 145% One Year Surge? - Yahoo Finance
Precigen Earnings Call Signals Powerful Launch Momentum - tipranks.com
Analyst Upgrade: Whats the beta of Precigen Inc stockMarket Weekly Review & Fast Gain Stock Tips - baoquankhu1.vn
Precigen: The Best Potential Blockbuster You've Never Heard Of (Your ENT Has) - Seeking Alpha
These Analysts Boost Their Forecasts On Precigen Following Q4 Results - Benzinga
Precigen (PGEN) Soars 26% Despite Missed Revenue Estimates - gurufocus.com
Precigen (NASDAQ:PGEN) Shares Gap Up Following Analyst Upgrade - MarketBeat
Precigen (PGEN) Shares Surge on Positive Q1 Outlook Despite Earnings Miss - gurufocus.com
Olaplex, Kodiak Sciences, Precigen And Other Big Stocks Moving Higher On Thursday - Benzinga
Precigen (NASDAQ:PGEN) Price Target Raised to $9.00 at Citizens Jmp - MarketBeat
PGEN: Analyst Jason N. Butler Raises Price Target to $9 | PGEN S - gurufocus.com
H.C. Wainwright raises Precigen stock price target on sales growth - Investing.com UK
Precigen stock gains on Q1 2026 outlook (PGEN:NASDAQ) - Seeking Alpha
PGEN: HC Wainwright & Co. Raises Price Target to $10.00 | PGEN S - GuruFocus
H.C. Wainwright raises Precigen stock price target on sales growth By Investing.com - Investing.com India
Precigen (NASDAQ:PGEN) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
Precigen, Inc. (NASDAQ:PGEN) Q4 2025 Earnings Call Transcript - Insider Monkey
Precigen (PGEN) Reports Strong Q4 2025 with PAPZIMEOS Launch - gurufocus.com
Citizens raises Precigen stock price target on strong PAPZIMEOS sales - Investing.com UK
Citizens raises Precigen stock price target on strong PAPZIMEOS sales By Investing.com - Investing.com Australia
Precigen Achieves First Commercial Revenue in 2025 with FDA Approval and Strong US Launch of PAPZIMEOS for RRP - Minichart
Precigen Inc. 2025 Annual Report: Papzimeos Launch, UltraCAR-T & AdenoVerse Platform, Clinical Pipeline, Risks, and Competitive Landscape 33 34 35 38 40 54 - Minichart
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):